All Title Author
Keywords Abstract


Understanding the Etiology and Treatment Approaches of Schizophrenia: Theoretical Perspectives and Their Critique

DOI: 10.4236/ojpsych.2016.64030, PP. 253-261

Keywords: Schizophrenia, Theory, Neurobiology

Full-Text   Cite this paper   Add to My Lib

Abstract:

This paper reviewed genetic, neurodevelopmental, and neurobiological perspectives to understand the etiology and relevant treatment approaches of schizophrenia. Although genetic and neurodevelopmental theories provide a substantial contribution to the etiology of schizophrenia, neurobiological one has its dominant stance in which it can explain causative mechanisms of schizophrenia, identify targets for treatment, and predict outcomes well. According to the neurobiology, onset and course of schizophrenia are well supported by the alterations in neurotransmitters such as dopamine or serotonin. Based on this mechanism, antipsychotics have been widely used as one of the treatment approaches for schizophrenia. By following up the degree of patients’ responses to antipsychotics, treatment outcomes could be evaluated or predicted. Although neurobiology seldom provides information about identification or prevention of risk factors about schizophrenia compared to genetic and neurodevelopmental approaches, it has well-established scientific foundations, ability to guide treatment, applicability across age and culture, and usefulness as a research framework.

References

[1]  American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders. 4th Edition, Text Revision (DSM-IV-TR), American Psychiatric Association, Washington DC.
[2]  Gourion, D., Goldberger, C., Leroy, S., Bourdel, M.C., Olie, J.P. and Krebs, M.O. (2005) Age at Onset of Schizophrenia: Interaction between Brain-Derived Neurotrophic Factor and Dopamine D3 Receptor Gene Variants. Neuroreport, 16, 1407-1410.
http://dx.doi.org/10.1097/01.wnr.0000175245.58708.6b
[3]  Preti, A. and Miotto, P. (2005) Genetics, Perinatal Insult and Schizophrenia: The Mechanism Underlying an Increased Prevalence of Perinatal Complications among Individuals with a Diagnosis of Schizophrenia? Current Psychiatry Reviews, 1, 139-150.
http://dx.doi.org/10.2174/1573400054065596
[4]  Zuchner, S., Roberts, S.T., Speer, M.C. and Beckham, J.C. (2007) Update on Psychiatric Genetics. Genetics in Medicine, 9, 332-340.
http://dx.doi.org/10.1097/GIM.0b013e318065a9fa
[5]  Sullivan, P.F. (2008) Schizophrenia Genetics: The Search for a Hard Lead. Current Opinion in Psychiatry, 21, 157-160.
http://dx.doi.org/10.1097/YCO.0b013e3282f4efde
[6]  Rietkerk, T., Boks, M.P., Sommer, I.E., Liddle, P.F., Ophoff, R.A. and Kahn, R.S. (2008) The Genetics of Symptom Dimensions of Schizophrenia: Review and Meta-Analysis. Schizophrenia Research, 102, 197-205.
http://dx.doi.org/10.1016/j.schres.2008.01.023
[7]  Hall, J., Romaniuk, L., McIntosh, A.M., Steele, J.D., Johnstone, E.C. and Lawrie, S.M. (2009) Associative Learning and the Genetics of Schizophrenia. Trends in Neurosciences, 32, 359-365.
http://dx.doi.org/10.1016/j.tins.2009.01.011
[8]  Taylor, R. and Langdon, R. (2006) Understanding Gender Differences in Schizophrenia: A Review of the Literature. Current Psychiatry Reviews, 2, 255-265.
http://dx.doi.org/10.2174/157340006776875987
[9]  Schlotz, W. and Phillips, D.I. (2009) Fetal Origins of Mental Health: Evidence and Mechanisms. Brain Behavior and Immunity, 23, 905-916.
http://dx.doi.org/10.1016/j.bbi.2009.02.001
[10]  Keshavan, M.S., Tandon, R., Boutros, N.N. and Nasrallah, H.A. (2008) Schizophrenia, “Just the Facts”: What We Know in 2008 Part 3: Neurobiology. Schizophrenia Research, 106, 89-107.
http://dx.doi.org/10.1016/j.schres.2008.07.020
[11]  Reif, A., Schmitt, A., Fritzen, S. and Lesch, K.P. (2007) Neurogenesis and Schizophrenia: Dividing Neurons in a Divided Mind? European Archives of Psychiatry and Clinical Neurosciences, 257, 290-299. http://dx.doi.org/10.1007/s00406-007-0733-3
[12]  Bender, W., Albus, M., Moller, H.J. and Tretter, F. (2006) Towards Systemic Theories in Biological Psychiatry. Pharmacopsychiatry, 39, S4-S9.
http://dx.doi.org/10.1055/s-2006-931482
[13]  Goff, D.C. (2005) Pharmacologic Implications of Neurobiological Models of Schizophrenia. Harvard Review of Psychiatry, 13, 352-359.
http://dx.doi.org/10.1080/10673220500433262
[14]  Wong, A.H. and Van Tol, H.H. (2003) Schizophrenia: From Phenomenology to Neurobiology. Neuroscience & Biobehavioral Reviews, 27, 269-306.
http://dx.doi.org/10.1016/S0149-7634(03)00035-6
[15]  Sadock, B. and Sadock, V. (2007) Synopsis of Psychiatry. Lippincott, Williams & Wilkins, Philadelphia.
[16]  Pantelis, C., Yucel, M., Bora, E., Fornito, A., Testa, R., Brewer, W.J., Velakoulis, D. and Wood, S.J. (2009) Neurobiological Markers of Illness Onset in Psychosis and Schizophrenia: The Search for a Moving Target. Neuropsychology Review, 19, 385-398.
http://dx.doi.org/10.1007/s11065-009-9114-1
[17]  Prasad, K.M., Sahni, S.D., Rohm, B.R. and Keshavan, M.S. (2005) Dorsolateral Prefrontal Cortex Morphology and Short-Term Outcome in First-Episode Schizophrenia. Psychiatry Research, 140, 147-155.
http://dx.doi.org/10.1016/j.pscychresns.2004.05.009
[18]  Wood, S.J., Berger, G.E., Lambert, M., Conus, P., Velakoulis, D., Stuart, G.W., Desmond, P., McGorry, P.D. and Pantelis, C. (2006) Prediction of Functional Outcome 18 Months after a First Psychotic Episode: A Proton Magnetic Resonance Spectroscopy Study. Archives of General Psychiatry, 63, 969-976.
http://dx.doi.org/10.1001/archpsyc.63.9.969
[19]  Nesvag, R., Saetre, P., Lawyer, G., Jonsson, E.G. and Agartz, I. (2009) The Relationship between Symptom Severity and Regional Cortical and Grey Matter Volumes in Schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 33, 482-490.
http://dx.doi.org/10.1016/j.pnpbp.2009.01.013
[20]  Cohen, A.S., Iglesias, B. and Minor, K.S. (2009) The Neurocognitive Underpinnings of Diminished Expressivity in Schizotypy: What the Voice Reveals. Schizophrenia Research, 109, 38-45.
http://dx.doi.org/10.1016/j.schres.2009.01.010
[21]  McGrath, J.J. and Richards, L.J. (2009) Why Schizophrenia Epidemiology Needs Neurobiology and Vice Versa. Schizophrenia Bulletin, 35, 577-581.
http://dx.doi.org/10.1093/schbul/sbp004
[22]  Nelson, B., Fornito, A., Harrison, B.J., Yucel, M., Sass, L.A., Yung, A.R., Thompson, A., Wood, S.J., Pantelis, C. and McGorry, P.D. (2009) A Disturbed Sense of Self in the Psychosis Prodrome: Linking Phenomenology and Neurobiology. Neuroscience & Biobehavioral Review, 33, 807-817.
http://dx.doi.org/10.1016/j.neubiorev.2009.01.002
[23]  Tretter, F. and Scherer, J. (2006) Schizophrenia, Neurobiology and the Methodology of Systemic Modeling. Pharmacopsychiatry, 39, S26-S35.
http://dx.doi.org/10.1055/s-2006-931486
[24]  Exner, C., Nehrkorn, B., Martin, V., Huber, M., Shiratori, K. and Rief, W. (2008) Sex-De- pendent Hippocampal Volume Reductions in Schizophrenia Relate to Episodic Memory Deficits. Journal of Neuropsychiatry& Clinical Neurosciences, 20, 227-230.
http://dx.doi.org/10.1176/jnp.2008.20.2.227

Full-Text

comments powered by Disqus